Related Experiment Video
Updated: Nov 11, 2025

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
Gene Therapies for Transfusion-Dependent b-Thalassemia
1Division of Pediatric Bone Marrow Transplant, Department of Pediatrics, University of California, San Francisco, CA, USA. Correspondence to: Dr Sandeep Soni, Associate Clinical Professor, Division of Pediatric Bone Marrow Transplant, Department of Pediatrics, University of California, San Francisco, CA, 94158, USA. sandeep.soni@ucsf.edu.
Gene therapy offers a promising new treatment for beta-thalassemia, a severe anemia caused by genetic defects. Advances in gene editing and stem cell manipulation are paving the way for effective therapies, especially for patients without transplant donors.
Area of Science:
- Hematology
- Genetics
- Molecular Biology
Background:
- Beta-thalassemia is a prevalent monogenic disease causing severe anemia due to defective beta-globin production.
- Current treatments like blood transfusions and hematopoietic stem cell transplantation have limitations.
Purpose of the Study:
- To review the current status of gene therapy approaches for transfusion-dependent beta-thalassemia.
- To discuss early clinical trial results and future prospects of gene therapy.
Main Methods:
- Ex-vivo genetic manipulation of human hematopoietic stem cells.
- Utilizing technological advances in genome sequencing, stem cell selection, viral vectors, transduction, and gene editing.
Main Results:
- Gene therapy strategies demonstrate potential for significant clinical benefit in beta-thalassemia patients.
- Early clinical trials show promising results for gene-edited hematopoietic stem cells.
Conclusions:
- Gene therapy is anticipated to become a viable treatment option for beta-thalassemia.
- It offers a potential alternative to hematopoietic stem cell transplantation for patients lacking compatible donors.
More Related Videos
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
12:04Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
Published on: March 10, 2023
Related Concept Videos
Gene Therapy
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
iPS Cell Differentiation
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...